CardioLogs ECG Analysis Platform vs PMcardio

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cardiologs Technologies (now part of Philips)
VS
by Powerful Medical

AI Verdict

Both CardioLogs ECG Analysis Platform and PMcardio are highly comparable AI-powered ECG analysis tools designed to assist healthcare professionals in diagnosing cardiac conditions. While both offer rapid and accurate interpretations, PMcardio distinguishes itself with a freemium pricing model and specific features like STEMI/OMI and reduced LVEF detection with visual AI explainability, whereas CardioLogs emphasizes multi-device compatibility and integration within the Philips ecosystem.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is comprehensive, high-volume ECG data analysis from a variety of cardiac monitoring devices, including Holters, smartwatches, and ECG patches. This cloud-based solution is ideal for practices and hospitals requiring efficient arrhythmia detection and diagnosis across a broad spectrum of ECG sources, with a focus on reducing false positives in long-term recordings.

View CardioLogs ECG Analysis Platform →

Choose PMcardio if…

Choose PMcardio if you require rapid, point-of-care ECG interpretation for over 50 cardiac conditions, particularly in emergency or general practice settings where quick, expert-level insights are crucial. Its mobile app accessibility, freemium model, and features like AI explainability and detection of subtle STEMI/OMI make it well-suited for individual clinicians or smaller practices seeking an immediate diagnostic aid.

View PMcardio →

When choosing between CardioLogs ECG Analysis Platform and PMcardio, physicians should consider their primary use case and desired deployment. CardioLogs, now a Philips solution, excels in comprehensive, high-volume ECG data analysis from various cardiac monitoring devices, making it ideal for practices managing extensive Holter, smartwatch, or ECG patch data. Its cloud-based SaaS deployment and pay-per-ECG model cater to institutions needing scalable, integrated solutions for arrhythmia detection and diagnosis.

In contrast, PMcardio offers a more immediate, point-of-care interpretation experience, best suited for rapid assessment of over 50 cardiac conditions. Its mobile app and web platform, coupled with a freemium pricing model, make it accessible for individual clinicians or smaller practices seeking quick, expert-level ECG interpretations, including specific features like STEMI/OMI and reduced LVEF detection with visual AI explainability.

The key practical difference lies in their deployment and pricing structures: CardioLogs is a cloud-based enterprise solution with a per-ECG fee, while PMcardio offers mobile accessibility and a freemium model. Physicians prioritizing high-throughput, multi-device ECG analysis and EHR integration will likely find CardioLogs more suitable. Conversely, those needing rapid, on-the-go ECG interpretations with a focus on immediate clinical decision support may prefer PMcardio.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform PMcardio
Pricing Contact sales for customized quote Freemium
Deployment Cloud-based (SaaS) Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, along with enterprise integrations, providing flexibility for various clinical settings and individual use. Its freemium model allows users to experience the tool before committing, and user reviews highlight its intuitive interface and ability to digitize even poor-quality ECGs. Cardiologs is cloud-based and offers a user-friendly interface, but its primary deployment is geared towards a platform for analysis rather than a direct mobile interpretation tool for individual clinicians at the point of care.

Clinical Value

PMcardio

PMcardio is clinically validated in over 25 studies and detects more than 50 cardiac conditions, including advanced features like STEMI/OMI detection (Queen of Heartsu2122) and reduced LVEF detection (LVsenseu2122), with visual AI explainability (ECGxplainu2122). Cardiologs, while FDA-cleared and supported by over 20 publications, focuses on arrhythmia detection and analysis of ECG data from various devices, and was the first AI solution approved by the FDA for ECG analysis in 2017.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model with a free plan for 5 ECG analyses per month and a clear Pro Plan for unlimited use and advanced features. This allows users to assess its value before a financial commitment. Cardiologs requires contacting sales for a customized quote, with pricing based on a 'pay per ECG' model, which lacks transparency for initial evaluation.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Cardiologs is a Philips solution, indicating robust integration capabilities and secure cloud hosting (ISO/IEC 27001 certified AWS servers), with EHR integration. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, unlimited users and locations, and adheres to GDPR, HIPAA, ISO 27001, and SOC 2 Type II standards.

Innovation

PMcardio

PMcardio showcases significant innovation with its 'Queen of Hearts' for STEMI/OMI detection, 'LVsense' for reduced LVEF, and 'ECGxplain' for visual AI explainability, providing transparency into AI's decision-making. Cardiologs, while pioneering as the first FDA-cleared AI for ECG analysis in 2017 and utilizing deep neural networks, focuses on efficient arrhythmia detection and analysis.

Support & Docs

PMcardio

PMcardio provides a Help Center, FAQ, and a blog with in-depth information, along with in-app support chat. Cardiologs mentions customizable reports and integration, implying documentation and support for implementation, but specific details on publicly available support resources are less explicit in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform PMcardio
Tool Name CardioLogs ECG Analysis Platform PMcardio
Company Cardiologs Technologies (now part of Philips) Powerful Medical
Tagline Reinventing cardiology diagnostics with medical-grade AI and cloud technology. AI that reads ECGs in seconds
Key Features (Examples) AI-Powered ECG Analysis (Deep Neural Networks), Multi-Device Compatibility (Holter, smartwatches, ECG patches), Automated Arrhythmia Detection (e.g., AFib, VT) Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), ECGxplainu2122 - Visual AI Explainability with heatmaps
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cardiologs is a cloud-based platform designed for integration with EHR systems, and it can also interface with other computer-based ECG systems. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, aiming for seamless workflow alignment and interoperability across various care settings.
Cardiologs has demonstrated a sensitivity of 97% and a positive predictive value (PPV) of 91% for detecting Atrial Fibrillation (AF). PMcardio has shown an 86% sensitivity and 92% specificity for major ECG abnormalities, with near-perfect accuracy (97% sensitivity, 99% specificity) for AF detection in primary care. For STEMI detection, PMcardio's Queen of Hearts platform has demonstrated 92% sensitivity and 81% specificity, and has been shown to reduce false positive cath lab activations.
Cardiologs aims to reduce the burden of ECG analysis, suggesting a focus on ease of use, and offers support through Philips. PMcardio is designed for speed and simplicity, and its AI explainability feature (ECGxplainu2122) may aid in understanding its interpretations. PMcardio also provides treatment recommendations based on ESC guidelines, which could reduce the need for physicians to keep up with constantly changing guidelines.
Cardiologs provides interpretation results to physicians on an advisory basis, in conjunction with their clinical judgment. PMcardio generates professional PDF diagnostic reports that can be exported and integrated into EHRs, including digitized ECGs, patient information, diagnoses, and treatment recommendations, which could serve as an audit trail.
Cardiologs is a cloud-based platform that facilitates collaboration between colleagues, facilities, and within care or service networks. PMcardio for Organizations is built for multi-pathway, multi-site cardiac care delivery, offering one integration, one contract, and one security review for health systems.
Cardiologs is particularly powerful for long-term ambulatory ECG recordings, aiding in the efficient analysis of continuous ECGs for arrhythmia detection. PMcardio offers a broader range of detection for over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, and provides guideline-adherent treatment recommendations, making it valuable at the point of care for various healthcare professionals, including in emergency and primary care settings.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.